{
    "2019-08-18": [
        [
            {
                "time": "",
                "original_text": "医药板块继续分化 看好两类股估值与业绩双修复",
                "features": {
                    "keywords": [
                        "医药板块",
                        "分化",
                        "估值修复",
                        "业绩修复"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}